You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsing-remitting MS

Showing 1 - 25 of 3,216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Integrated Digital Solutions in Medical Care of Multiple

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • MS Care Platform (icobrain ms and icompanion ms)
  • (no location specified)
Jul 10, 2023

Multiple Sclerosis Trial in Genova (7-day Fasting-Mimicking Diet (7-DAY FMD))

Active, not recruiting
  • Multiple Sclerosis
  • 7-day Fasting-Mimicking Diet (7-DAY FMD)
  • Genova, Italy
    Ospedale San Martino
Sep 8, 2023

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • West Orange, New Jersey
      Kessler Foundation
    Oct 12, 2022

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

    Recruiting
    • Multiple Sclerosis
    • +5 more
    • Amsterdam, Netherlands
      Amsterdam UMC, location VUmc
    Apr 17, 2023

    Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis Trial in United States (ANK-700, Placebo)

    Recruiting
    • Multiple Sclerosis (MS)
    • Relapsing Remitting Multiple Sclerosis
    • Cullman, Alabama
    • +14 more
    Dec 13, 2022

    Multiple Sclerosis Trial in Amsterdam (MS Sherpa)

    Recruiting
    • Multiple Sclerosis
    • MS Sherpa
    • Amsterdam, Netherlands
      Amsterdam UMC, locatie VUmc
    Nov 4, 2023

    Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • +6 more
    • Clemastine Fumarate
    • Placebo
    • San Francisco, California
      Sandler Neurosciences Building, Neurological Clinical Research U
    Jan 23, 2023

    Mechanistic Studies of Teriflunomide in RRMS

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Ann Arbor, Michigan
      University of Michigan
    Jul 27, 2022

    Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • 3 mg Melatonin
    • 5 mg Melatonin
    • Portland, Oregon
      Providence MS Center
    May 5, 2022

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • 18F-DPA-714 and 18F-FDG
    • Paris, France
    • +1 more
    Sep 14, 2022

    Multiple Sclerosis Trial (Natalizumab)

    Not yet recruiting
    • Multiple Sclerosis
    • (no location specified)
    Jun 21, 2023

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Hamburg (Understanding MRI in

    Active, not recruiting
    • Multiple Sclerosis
    • +2 more
    • Understanding MRI in MS (website)
    • Control website
    • Hamburg, Germany
      University Medical Centre Hamburg-Eppendorf
    Dec 5, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in Omaha (BrainHQ cognitive training, BrainHQ control games)

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • BrainHQ cognitive training
    • BrainHQ control games
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Apr 22, 2022

    Multiple Sclerosis (MS) Symptoms

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
      • Louisville, Kentucky
        University of Louisville (recruiting nationwide)
      Dec 13, 2021

      Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

      Recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • Chisinau, Moldova, Republic of
        Republican Clinical Hospital, ARENSIA Exploratory Medicine
      Jun 8, 2022

      Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

      Active, not recruiting
      • Relapsing-remitting Multiple Sclerosis
      • Stockholm, Sweden
        Fredrik Piehl
      Apr 8, 2022

      Relapsing-Remitting Multiple Sclerosis Trial in Columbus (Step Tracking, Water Tracking)

      Active, not recruiting
      • Relapsing-Remitting Multiple Sclerosis
      • Step Tracking
      • Water Tracking
      • Columbus, Ohio
        Department of Psychology, The Ohio State University
      Jan 24, 2022

      Relaxin in Multiple Sclerosis (MS)

      Recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • Blood Draw
      • Lumbar Puncture
      • Portland, Oregon
        Providence MS Center
      Feb 2, 2022

      Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis

      Recruiting
      • Relapsing-Remitting Multiple Sclerosis
        • Coventry, United Kingdom
        • +7 more
        May 20, 2022

        Quality of Life in Clinical Practice in Germany for

        Recruiting
        • Multiple Sclerosis, Relapsing-Remitting
          • Dresden, Saxony, Germany
            Universitätsklinikum Dresden, MS Ambulanz
          Apr 12, 2022

          Multiple Sclerosis, Relapsing-Remitting Trial in Yvoir (Multiparametric assessment)

          Recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • Multiparametric assessment
          • Yvoir, Namur, Belgium
            CHU UCL Namur site Godinne
          Aug 19, 2022

          Relapsing Remitting Multiple Sclerosis Trial in Norway (Rituximab, Ocrelizumab)

          Recruiting
          • Relapsing Remitting Multiple Sclerosis
          • Bergen, Norway
          • +10 more
          Mar 18, 2022

          Multiple Sclerosis, Relapsing-Remitting Trial in Bordeaux (Clinical assessment, Ecological evaluation, Neuropsychological

          Active, not recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • Clinical assessment
          • +4 more
          • Bordeaux, France
            CHU de Bordeaux - Service de neurologie
          Feb 2, 2022

          Multiple Sclerosis, Relapsing-Remitting, Adult ALL, Vitamin D3 Deficiency Trial (25(OH)D3, vitamin D3)

          Not yet recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • +2 more
          • 25(OH)D3
          • vitamin D3
          • (no location specified)
          Apr 16, 2022